<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "dexrazoxane inj VIAL">
<dose><value>500</value>
<value>1000</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>250 mg</value>
<value>500 mg</value>
</strength>
<frequency><value>ONCE</value>
<value>Q24H  </value>
</frequency>
<instruction><value>for 2 days. Administer dose over 1 to 2 hours. </value>
<value>Administer on third day off 3day protocol. Administer dose over 1 to 2 hours.</value>
</instruction>
<volume></volume>
<units><value>mg/m2</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>10:1 dosing ratio for use with DOXOrubicin as a cardioprotectant. Maintain 10:1 dosing ratio where DOXOrubicin dose is decreased. Recoomend reducing dose by 50% in patients with CrCl less than 40 mL/minute.</value>
<value>10:1 dosing ratio for use with epirubicin as a cardioprotectant. Maintain 10:1 dosing ratio when epirubicin dose is decreased. Recommend reducing dose 50% in patients with CrCl less than 40 mL/minute.</value>
<value>Extravasation Treatment. 3 day protocol. First dose should be initiated as soon as possible (within the first 6 hours after extravasation) with subsequent doses 24 hours apart. MAXIMUM dose (DAY 1 &amp; 2): 2000 mg/day. Recommend reducing dose 50% in patients with CrCl less than 40 mL/minute.</value>
<value>Extravasation Treatment. 3 day protocol. First dose should be initiated as soon as possible (within the first 6 hours after extravasation) with subsequent doses 24 hours apart. MAXIMUM dose (DAY 3): 1000 mg/day. Recommend reducing dose 50% in patients with CrCl less and 40 mL/minute.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3583</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3584</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>FR</value>
</AHSFormularyStatus>
<HighAlert></HighAlert>
</drug>